Immunic AG | Finanzwire

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Home
Companies
Immunic AG

BRIEF

published on 11/26/2025 at 12:35, 8 days 17 hours ago

Immunic to Join Evercore ISI Healthcare Conference in December

Biotechnology Immunic Investor Meetings Healthcare Conference Neurologic Diseases
PRESS RELEASE

published on 11/26/2025 at 12:30, 8 days 17 hours ago

Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December
Immunic to participate in the 8th Annual Evercore ISI Healthcare Conference in December. Dr. Daniel Vitt to speak at fireside chat on novel oral therapies for neurologic and gastrointestinal diseases

Gastrointestinal Diseases Immunic Neurologic Diseases Evercore ISI Healthcare Conference Daniel Vitt
BRIEF

published on 11/13/2025 at 12:35, 21 days 17 hours ago

Immunic, Inc. Announces Third Quarter 2025 Financial Results and Updates

Financial Results Clinical Trials Immunic, Inc. Multiple Sclerosis Vidofludimus Calcium
PRESS RELEASE

published on 11/13/2025 at 12:30, 21 days 17 hours ago

Immunic, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Immunic, Inc. reports Q3 2025 financial results and provides corporate update, highlighting vidofludimus calcium's therapeutic potential in multiple sclerosis. Phase 3 ENSURE trial data expected by 2026

Financial Results Immunic Inc. Vidofludimus Calcium Phase 3 Trials MS Therapy
BRIEF

published on 10/29/2025 at 11:35, 1 month 6 days ago

Immunic to Participate in Key November Conferences

Biotechnology Immunic Conference Participation BIO-Europe Jefferies Conference
PRESS RELEASE

published on 10/29/2025 at 11:30, 1 month 6 days ago

Immunic to Participate in Industry and Investor Conferences in November
Immunic, Inc. to participate in industry and investor conferences in November, presenting clinical pipeline of therapies for inflammatory diseases

Investor Conferences Immunic Inc. Clinical Pipeline Inflammatory Diseases Industry Conferences
BRIEF

published on 10/01/2025 at 12:35, 2 months 3 days ago

Immunic to Engage in Key October Conferences

Biotechnology Immunic Inc. Investor Engagement Chronic Diseases Scientific Conferences
PRESS RELEASE

published on 10/01/2025 at 12:30, 2 months 3 days ago

Immunic to Participate in Scientific and Investor Conferences in October
Immunic, Inc. (Nasdaq: IMUX) to participate in scientific and investor conferences in October showcasing IMU-856 and vidofludimus calcium (IMU-838) data

Investor Conferences Immunic Inc. Scientific Conferences IMU-856 IMU-838
BRIEF

published on 09/25/2025 at 12:35, 2 months 9 days ago

Immunic Highlights Vidofludimus Calcium's Progress at ECTRIMS Congress

Multiple Sclerosis Immunic Vidofludimus Calcium Phase 2 Trial ECTRIMS
PRESS RELEASE

published on 09/25/2025 at 12:30, 2 months 9 days ago

Immunic Presented Key Vidofludimus Calcium Data at the 41st Congress of ECTRIMS, Highlighting Its Potential in Multiple Sclerosis
Immunic presented key Vidofludimus Calcium data at the 41st Congress of ECTRIMS, highlighting its potential in multiple sclerosis. The data underscore its neuroprotective potential and promise to slow disease progression

Multiple Sclerosis Immunic Vidofludimus Calcium ECTRIMS Congress Neuroprotective Potential

1 2 ... 8

Accesswire

Published on 12/05/2025 at 02:35, 3 hours 51 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 3 hours 56 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 5 hours 26 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 21 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 26 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 03:30, 2 hours 56 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 36 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 1 minute ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 11 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 16 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

Les Echos

Published on 12/04/2025 at 18:00, 12 hours 26 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 41 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 42 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 25 minutes ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE